
- TwitterTweet
- FacebookShare
- Share
- Jump to Comments
Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor
Novartis has signed an agreement to collaborate with Compact Imaging – to fund the development of a low-cost home-based monitor to detect disease progression in advanced cases of eye diseases, age-related macular degeneration (AMD) and diabetic retinopathy (DR) .
If approved, goggles used at a patient's home could record a test result and upload it over the internet for a specialist to review, thereby potentially reducing clinical visits, saving doctors' and patients' time while delivering cost and efficiency savings to healthcare systems .
This collaboration demonstrates Novartis’s ongoing commitment to eye care and improving patient outcomes for age-related macular degeneration (AMD) and diabetic retinopathy (DR).
1 Nasdaq. (2018). Compact Imaging Collaborates with Global Pharma to Accelerate Development of Home Monitor for Age-Related Macular Degeneration and Diabetic Retinopathy. [online] Available at: https://www.nasdaq.com/press-release/compact-imaging-collaborates-with-global-pharma-to-accelerate-development-of-home-monitor-for-20181025-00687 [Accessed 26 Nov. 2018].
2 Reynolds, J. (2018). Novartis to fund medtech startup's eye kit - Independent.ie. [online] Independent.ie. Available at: https://www.independent.ie/business/irish/novartis-to-fund-medtech-startups-eye-kit-37472133.html [Accessed 26 Nov. 2018].